{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:35:39Z","timestamp":1789986939447,"version":"4.0.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1681\/asn.2014090875","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T22:53:05Z","timestamp":1426719185000},"page":"2778-2788","source":"Crossref","is-referenced-by-count":21,"title":["Combined Deletion of Vhl and Kif3a Accelerates Renal Cyst Formation"],"prefix":"10.1681","volume":"26","author":[{"given":"Holger","family":"Lehmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Vicari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J.","family":"Frew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20230208","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005792-199711000-00001","article-title":"von Hippel-Lindau disease.","volume":"76","author":"Maher","year":"1997","journal-title":"Medicine (Baltimore"},{"key":"R2-22-20230208","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1535-6108(02)00071-5","article-title":"HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron.","volume":"1","author":"Mandriota","year":"2002","journal-title":"Cancer Cell"},{"key":"R3-22-20230208","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.4161\/cc.6.15.4518","article-title":"The VHL tumor suppressor: Riding tandem with GSK3beta in primary cilium maintenance.","volume":"6","author":"Thoma","year":"2007","journal-title":"Cell Cycle"},{"key":"R4-22-20230208","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ng.2699","article-title":"Integrated molecular analysis of clear-cell renal cell carcinoma.","volume":"45","author":"Sato","year":"2013","journal-title":"Nat Genet"},{"key":"R5-22-20230208","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/PAP.0b013e3181d98c9d","article-title":"Cystic renal tumors: New entities and novel concepts.","volume":"17","author":"Moch","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"R6-22-20230208","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/modpathol.2010.222","article-title":"VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma.","volume":"24","author":"von Teichman","year":"2011","journal-title":"Mod Pathol"},{"key":"R7-22-20230208","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"R8-22-20230208","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ncb899","article-title":"Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL.","volume":"5","author":"Hergovich","year":"2003","journal-title":"Nat Cell Biol"},{"key":"R9-22-20230208","doi-asserted-by":"crossref","first-page":"R526","DOI":"10.1016\/j.cub.2009.05.025","article-title":"The primary cilium as a complex signaling center.","volume":"19","author":"Berbari","year":"2009","journal-title":"Curr Biol"},{"key":"R11-22-20230208","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/modpathol.2008.132","article-title":"Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia.","volume":"22","author":"Schraml","year":"2009","journal-title":"Mod Pathol"},{"key":"R12-22-20230208","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1083\/jcb.200605092","article-title":"The von Hippel-Lindau tumor suppressor protein controls ciliogenesis by orienting microtubule growth.","volume":"175","author":"Schermer","year":"2006","journal-title":"J Cell Biol"},{"key":"R13-22-20230208","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1158\/0008-5472.CAN-06-0501","article-title":"Primary cilium formation requires von Hippel-Lindau gene function in renal-derived cells.","volume":"66","author":"Lutz","year":"2006","journal-title":"Cancer Res"},{"key":"R14-22-20230208","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1681\/ASN.2006020181","article-title":"Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein.","volume":"17","author":"Esteban","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R15-22-20230208","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/emboj.2008.96","article-title":"pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation.","volume":"27","author":"Frew","year":"2008","journal-title":"EMBO J"},{"key":"R16-22-20230208","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/ncb1579","article-title":"pVHL and GSK3beta are components of a primary cilium-maintenance signalling network.","volume":"9","author":"Thoma","year":"2007","journal-title":"Nat Cell Biol"},{"key":"R17-22-20230208","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1128\/MCB.02132-07","article-title":"Combined VHLH and PTEN mutation causes genital tract cystadenoma and squamous metaplasia.","volume":"28","author":"Frew","year":"2008","journal-title":"Mol Cell Biol"},{"key":"R18-22-20230208","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1073\/pnas.0836980100","article-title":"Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease.","volume":"100","author":"Lin","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-22-20230208","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2353\/ajpath.2007.060455","article-title":"Involvement of hypoxia-inducible transcription factors in polycystic kidney disease.","volume":"170","author":"Bernhardt","year":"2007","journal-title":"Am J Pathol"},{"key":"R20-22-20230208","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1681\/ASN.2013030209","article-title":"Hypoxia-inducible factor-1\u03b1 causes renal cyst expansion through calcium-activated chloride secretion.","volume":"25","author":"Buchholz","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R21-22-20230208","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/hmg\/ddn045","article-title":"Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia.","volume":"17","author":"Patel","year":"2008","journal-title":"Hum Mol Genet"},{"key":"R22-22-20230208","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/cmmi.238","article-title":"Kidney volume quantification using contrast-enhanced in vivo X-ray micro-CT in mice.","volume":"3","author":"Almajdub","year":"2008","journal-title":"Contrast Media Mol Imaging"},{"key":"R23-22-20230208","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/nm1675","article-title":"A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1.","volume":"13","author":"Piontek","year":"2007","journal-title":"Nat Med"},{"key":"R24-22-20230208","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.semcdb.2009.09.016","article-title":"Planar cell polarity and cilia.","volume":"20","author":"Fischer","year":"2009","journal-title":"Semin Cell Dev Biol"},{"key":"R26-22-20230208","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0022-5347(05)63998-5","article-title":"Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma.","volume":"169","author":"Horiguchi","year":"2003","journal-title":"J Urol"},{"key":"R27-22-20230208","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/cncr.22677","article-title":"Prognostic relevance of the mTOR pathway in renal cell carcinoma: Implications for molecular patient selection for targeted therapy.","volume":"109","author":"Pantuck","year":"2007","journal-title":"Cancer"},{"key":"R28-22-20230208","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/jso.10302","article-title":"Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth.","volume":"84","author":"Shin Lee","year":"2003","journal-title":"J Surg Oncol"},{"key":"R29-22-20230208","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/modpathol.3880551","article-title":"Intragenic PTEN\/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.","volume":"15","author":"Velickovic","year":"2002","journal-title":"Mod Pathol"},{"key":"R30-22-20230208","doi-asserted-by":"crossref","first-page":"16538","DOI":"10.1073\/pnas.1414789111","article-title":"Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis.","volume":"111","author":"Wang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R31-22-20230208","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.celrep.2014.04.018","article-title":"In vivo clonal analysis reveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regeneration.","volume":"7","author":"Rinkevich","year":"2014","journal-title":"Cell Rep"},{"key":"R32-22-20230208","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ncb1912","article-title":"VHL loss causes spindle misorientation and chromosome instability.","volume":"11","author":"Thoma","year":"2009","journal-title":"Nat Cell Biol"},{"key":"R33-22-20230208","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1158\/0008-5472.CAN-13-2040","article-title":"Tumor suppressor VHL functions in the control of mitotic fidelity.","volume":"74","author":"Hell","year":"2014","journal-title":"Cancer Res"},{"key":"R34-22-20230208","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1158\/0008-5472.CAN-05-3241","article-title":"Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor.","volume":"66","author":"Rankin","year":"2006","journal-title":"Cancer Res"},{"key":"R35-22-20230208","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/ncb2117","article-title":"Primary cilia regulate mTORC1 activity and cell size through Lkb1.","volume":"12","author":"Boehlke","year":"2010","journal-title":"Nat Cell Biol"},{"key":"R36-22-20230208","doi-asserted-by":"crossref","first-page":"e9239","DOI":"10.1371\/journal.pone.0009239","article-title":"Carboxy terminal tail of Polycystin-1 regulates localization of TSC2 to repress mTOR.","volume":"5","author":"Dere","year":"2010","journal-title":"PLOS One"},{"key":"R37-22-20230208","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease.","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R38-22-20230208","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy.","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat Med"},{"key":"R39-22-20230208","doi-asserted-by":"crossref","first-page":"34495","DOI":"10.1074\/jbc.C800170200","article-title":"Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2.","volume":"283","author":"Toschi","year":"2008","journal-title":"J Biol Chem"},{"key":"R40-22-20230208","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/01.ASN.0000016444.90348.50","article-title":"Epithelial-specific Cre\/lox recombination in the developing kidney and genitourinary tract.","volume":"13","author":"Shao","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R41-22-20230208","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1073\/pnas.98.4.1583","article-title":"Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.","volume":"98","author":"Haase","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R42-22-20230208","first-page":"4010","article-title":"Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.","volume":"60","author":"Ryan","year":"2000","journal-title":"Cancer Res"},{"key":"R43-22-20230208","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/emmm.201202231","article-title":"Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice.","volume":"5","author":"Albers","year":"2013","journal-title":"EMBO Mol Med"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201511000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:26:07Z","timestamp":1786130767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201511000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2014090875","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}